Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Medicine (Year 5) > Endocrinology (Thyroid) > Flashcards

Endocrinology (Thyroid) Flashcards

1
Q

Hyperthyroidism

A

describes the excessive production of thyroid hormones by the thyroid gland. Thyrotoxicosis is a term used to describe the clinical manifestations of excess circulating thyroid hormones due to any cause, including hyperthyroidism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Thyroid Physiology

A
  1. The hypothalamus releases thyrotropin-releasing hormone (TRH) which acts on the anterior pituitary, causing it to release thyroid-stimulating hormone (TSH).
  2. The TSH acts on the thyroid gland to produce thyroxine (T4) and triiodothyronine (T3).
  3. T4 is inactive and is converted to T3 peripherally.
  4. T3 and T4 exert negative feedback on the hypothalamus and pituitary.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

causes of hyperthyroidism

A
  • Graves’ disease
  • Toxic multinodular goitre
  • Toxic thyroid adenoma
  • Hashimoto’s thyroiditis (acute phase)
  • Subacute (de Quervain’s) thyroiditis (acute phase)
  • Drugs (e.g. amiodarone)
  • Post-partum thyroiditis (acute phase)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

presentation of hyperthyroidism

A
  • weight loss
  • increased appetite
  • restlessness
  • heat intolerance
  • tachycardia
  • palpitations
  • diarrhoea
  • sweating
  • tremor
  • anxiety - psychosis
  • oligomenorrhoea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

signs of hyperthyroidism

A
  • Sweaty and warm palms
  • Palmar erythema
  • Fine tremor
  • Tachycardia – can be atrial fibrillation:
  • Hair thinning/loss
  • Brisk reflexes
  • Goitre (swelling of the neck due to enlargement of the thyroid gland)
  • Proximal myopathy
  • Lid lag
  • Thyroid acropachy (nail clubbing)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

investigations for hyperthyroidism

A
  • TFT : TSH, T3, T4
  • thyroid autoantibodies
  • thyroid US
  • Radioactive iodine uptake testing (thyroid scintigraphy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TFT results for hyperthyroidism

A

TSH: low
T3: raised
T4: raised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Thyroid autoantibodies:

A
  • TSH receptor antibodies (TRAb): positive in Graves’ disease
  • Thyroid peroxidase antibodies (TPOAb): positive in Hashimoto’s thyroiditis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Graves’ disease

A

is an autoimmune condition characterised by the presence of TSH receptor antibodies (TRAb) binding to the TSH receptor, stimulating the thyroid gland to increase secretion of T3 and T4 leading to hyperthyroidism. Since more T3 and T4 are made, negative feedback reduces the release of TSH from the anterior pituitary gland.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

RF for graves disease

A

Smoking
Family history
Female sex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

signs of graves

A

1) Eye signs:

  • Exophthalmos – bulging/protruding eyeballs
  • Ophthalmoplegia – paralysis/weakness of one or more extraocular muscles

2) Pretibial myxoedema:
3) Non-pitting oedema

Eye signs usually precede pretibial myxoedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

investigations for graves

A

TFTs:

  • Increased T3 and T4
  • Reduced TSH

Thyroid autoantibodies:

  • TSH receptor antibodies (TRAb): positive in 90% of patients

Radioactive iodine uptake testing:

  • Uptake is increased, diffuse, and homogenous (consistent throughout the thyroid gland)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

management of Graves in primary care i.e. before referral to secondary care

A
  • 1st-line: propranolol for symptomatic relief + referral to endocrinology
  • If symptoms are troublesome while awaiting referral: offer carbimazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

management of Graves in secondary care:

A
  • 1st-line: carbimazole
  • 2nd-line: propylthiouracil
  • Consider radioiodine treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

thyroid eye disease

A

an autoimmune condition resulting in inflammation and swelling of the extraocular muscles, fatty tissue and connective tissue within the orbit.

Pathophysiology:

Closely correlating with Graves’ disease, patients with TED have been found to have elevated levels of antibodies against thyroid-stimulating hormone (TSH) receptors, which are expressed in orbital fat and connective tissue.

Studies also attribute increased fibroblast activity as well as the accumulation of collagen and hyaluronic acid to the enlargement and fibrosis of the extraocular muscles.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

management of thryoid eye disease

A
  • correct hyperthyroidims
  • smoking cessation!!
  • artificial tears and tapes
  • steroids in severe cases e.g. IV methylprednisolone as first line form compressive optic neuropathy
  • surgical decompression and lid surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Toxic multinodular goitre (TMNG)

A

is characterised by thyroid nodules that secrete excess T3 and T4 autonomously (without the need for TSH to stimulate them) leading to hyperthyroidism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Risk Factors for Toxic multinodular goitre

A
  • Iodine deficiency – more common in developing countries
  • Head and neck irradiation
  • Female sex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

investigations for toxic multinodular goitre

A

TFTs:
* Increased T3 and T4
* Reduced TSH

Thyroid autoantibodies:
* None are present

Radioactive iodine uptake testing:
* Uptake is patchy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

management of toxic multinodular goitre

A

radioactive iodine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

radioactive iodine side effect

A

hypothyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

toxic thyroid adenoma

A

A toxic adenoma is a singular thyroid nodule that releases thyroid hormones autonomously. They are almost always benign.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Investigations for toxic thyroid adenoma

A

TFTs:
* Increased T3 and T4
* Reduced TSH

Thyroid autoantibodies:
* None are present

Radioactive iodine uptake testing:
* Uptake is in a focal area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

managemnt of toxic thyroid adenoma

A

radioactive iodine or surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Hashimoto’s thyroiditis:

A
  • This can cause hyperthyroidism initially (in the acute phase), followed by hypothyroidism.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Subacute (de Quervain’s) thyroiditis:

A

Can cause hyperthyroidism initially (in acute phase), followed by hypothyroidism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Post–partum thyroiditis:

A

Can cause hyperthyroidism initially (in acute phase), followed by hypothyroidism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

A thyrotoxic crisis

A

is a potentially life-threatening complication of hyperthyroidism. It can lead to hyperthermia, cardiac arrhythmias heat failure, multiple organ failure, and sepsis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

causes of thytrotoxic crisis

A
  • Infection
  • Trauma or surgery
  • Withdrawal/non-compliance with antithyroid medication
  • Myocardial infraction or stroke
  • Pulmonary embolism
  • Childbirth
  • Overdose of levothyroxine
  • Diabetic ketoacidosis, hyperosmolar hyperglycaemic state
  • Hypoglycaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Presentation of thyrotoxic crisis

A

Patients generally present with sudden-onset severe hyperthyroidism:

  • Hyperpyrexia (>41.0ºC)
  • Tachycardia >140 bpm
  • Arrhythmias (e.g. atrial fibrillation)
  • Nausea
  • Diarrhoea
  • Confusion
  • Psychosis
  • Seizures
  • Coma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Investigations for thyrotoxicosis

A

TFTs:

  • Elevated T3 and T4
  • Reduced TSH

ECG
Chest x-ray
ABGs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

management of thyrotoxic crisis

A
  • 1st-line: beta-blockers, propylthiouracil, and hydrocortisone
  • High levels of thyroid hormone can increase the breakdown of cortisol, increasing the risk of adrenal insufficiency. Hydrocortisone is given to mitigate this risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what is subclinical hyperthyroidism

A
  • suppressed TSH below the normal ref range but T3/T4 are within normal ref range
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

most common cause of subclinical hyperthyroidism is

A

toxic multinodular goitre
- more common i elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

investigations for subclinical hyperthyroidism

A

Thyroid function tests (TFTs) show low TSH and normal FT4 and FT3. These should be repeated 3 months after to exclude other causes of transient TSH suppression. If after at least 3 months of repeat testing, TSH is still low but FT4 and FT3 are normal, subclinical hyperthyroidism is diagnosed.

36
Q

Referral for subclinical hyperthyroidism

A

1) Urgently refer to secondary care via a suspected cancer pathway if:

  • Goitre, nodule, or structural change is present or if malignancy is suspected
  • TFTs are generally normal in people with thyroid cancer

2) Refer to an endocrinologist if:

  • Subclinical hyperthyroidism is diagnosed as above and there is evidence of thyroid disease (e.g. goitre, positive autoantibodies, or symptoms of hyperthyroidism)
37
Q

types of thyroid cancer

A
  • Papillary thyroid carcinoma (most common)
  • Follicular thyroid carcinoma (second most common)
  • Medullary thyroid cancer(MEN 2A or 2B)
  • Anaplastic thyroid cancer
  • Thyroid lymphoma
38
Q

Papillary thyroid carcinoma:

A
  • Most common form of thyroid cancer – around 70%
  • More common in women aged 35-40 years
  • Metastases tend to spread locally in the neck
  • The prognosis is excellent
39
Q

Follicular thyroid carcinoma:

A
  • Second most common form of thyroid cancer – around 10%
  • May infiltrate the neck but tends to metastasise to the lung and bones
  • More common in women aged 30-60 years
40
Q

Medullary thyroid cancer:

A
  • Cancer of parafollicular calcitonin-producing C cells of the thyroid
  • Can be sporadic, but can be inherited as part of multiple endocrine neoplasia (MEN) 2A or 2B
  • Serum calcitonin is often raised
41
Q

Anaplastic thyroid cancer:

A
  • One of the most aggressive cancers in humans
  • Most common in people aged 55-65 years of age
  • Usually infiltrates the neck leading to compression (cough, vocal cord paralysis, dysphagia, dyspnoea etc.)
  • Mean survival is often <6 months, regardless of treatments given
42
Q

Thyroid lymphoma:

A

Associated with Hashimoto’s thyroiditis
More common in women around the age of 65 years
Usually a rapidly growing mass in the neck which can lead to symptoms due to compression

43
Q

investigations for thyroid cancer

A

TFTs:

  • Usually normal

Neck ultrasound:

  • Shows masses/nodules
  • Features seen include macrocalcifications, irregular borders, intramodular blood flow, and peripheral halo

Fine-needle aspiration cytology (FNAC):

  • Allows for histological diagnosis

Radioactive iodine uptake testing:

  • ‘Cold areas’ are areas of abnormally low uptake and are seen in thyroid cancer
44
Q

management of thyroid cancer

A

Options involve a total thyroidectomy, radioactive iodine, and radiotherapy.

45
Q

Hypothyroidism

A

describes the inadequate production of thyroid hormones by the thyroid gland. It may also be referred to as an underactive thyroid.

46
Q

most common cause of hypothyroidism in the UK

A
  • hashimotos thyroiditis
  • iodine deficiency in the developing world
47
Q

hypothyroidism can be

A

primary
secondary

48
Q

Primary hypothyroidism

A
  • Hashimoto’s thyroiditis
  • Iatrogenic (e.g. radiotherapy to the neck, radioactive iodine treatment)
  • Iodine deficiency
  • Some drugs (e.g. amiodarone and lithium)
  • Infiltrative causes (e.g. sarcoidosis or haemochromatosis)
  • Congenital (e.g. dysgenesis)
  • Postpartum thyroiditis
49
Q

Secondary hypothyroidism

A
  • Any cause of hypopituitarism (e.g. neoplasm, trauma, infection, radiotherapy)
  • Any cause of hypothalamic dysfunction (e.g. neoplasm, trauma)
50
Q

presentation of hypothyroidism

A
  • Fatigue
  • Lethargy
  • Cold intolerance:
  • Dry skin
  • Hair loss
  • Constipation
  • Decreased appetite with weight gain
  • Poor memory
  • Difficulty with concentration
  • Reduced libido
  • Menorrhagia
51
Q

signs of hypothyroidism

A
  • Dry and coarse skin
  • Cold peripheries
  • Myxoedema:
  • Non-pitting oedema of the face, hands, and feet
  • Bradycardia
  • Decreased tendon reflexes
  • Carpal tunnel syndrome
52
Q

investigations for hypothyroidism

A

Thyroid function tests (TFTs):

  • These measure TSH, T3, and T4
  • TSH: elevated
  • T3: reduced
  • T4: reduced

Thyroid autoantibodies:

  • Thyroid peroxidase antibodies (TPOAb): positive in Hashimoto’s thyroiditis

Thyroid ultrasound:

  • Considered if a goitre is detected

Radioactive iodine uptake testing (thyroid scintigraphy):

  • Helps distinguish between different causes of goitre
  • More findings are discussed in each cause below
53
Q

Hashimoto’s thyroiditis

A

is an autoimmune condition characterised by the destruction of the thyroid gland cells. Although it causes hypothyroidism, there can be hyperthyroidism in the acute phase.

54
Q

rf for hashimotos

A

The presence of another autoimmune disease (e.g. type 1 diabetes)

55
Q

management of Hashimotos

A
  • 1st-line: lifelong thyroid hormone replacement (levothyroxine)
  • Surgery for goitres may be considered (e.g. if there are obstructive symptoms)
56
Q

Adverse effects of thyroid hormone replacement therapy

A

Adverse effects of thyroid hormone replacement therapy can be due to over-treatment, which can lead to features of hyperthyroidism such as:

  • Weight loss
  • Osteoporosis
  • Arrhythmia (atrial fibrillation)
57
Q

Subacute (de Quervain’s) thyroiditis

A

inflammation of the thyroid gland leading to a triphasic presentation of hyperthyroidism, then hypothyroidism, then a return to euthyroidism.

It is thought to be due to a viral infection.

  1. Hyperthyroid phase – 4-6 weeks in length
  2. Hypothyroid phase – 2-6 months in length
  3. Euthyroid phase
58
Q

management of subacute (de Quervains) thyroiditis

A
  • 1st-line: supportive management (e.g. NSAIDs for thyroid pain)
  • In some severe cases, corticosteroids may be used.
    *
59
Q

drugs which can cause hypothyroidism

A
  • Lithium – reduces the activity of thyroid hormone.
  • Amiodarone – is structurally similar to thyroid hormones and contains iodine, meaning it can lead to both hyper- and hypothyroidism.
60
Q

Subclinical hypothyroidism:

A

TSH: high
T3 and T4: normal

61
Q

investigations for subclinical hypothyroidism

A

Thyroid function tests (TFTs) show elevated TSH and normal FT4 and FT3. These should be repeated after 3 months to exclude other causes of transiently raised TSH.

Thyroid peroxidase antibody (TPOAb) testing may be considered. If positive, this can predict progression to overt hypothyroidism.

62
Q

management of subclinical hypothyroidism

A
  1. TSH >10 mU/L: consider offering levothyroxine
  2. TSH 5.5 – 10 mU/L:
    * If <65 years old and symptoms of hypothyroidism: 6-month trial of levothyroxine
    * In older people: watch and wait
    * If asymptomatic: observe and repeat TFTs in 6 months
63
Q

Myxoedema coma

A

is an extreme, decompensated form of hypothyroidism. In this case, decompensation describes the inability of the body to adapt to untreated hypothyroidism.

64
Q

risk factors for Myxoedema coma

A

Risk Factors

  • Being elderly
  • Hypothermia
  • Infection (e.g. pneumonia)
  • Some drugs (amiodarone, beta-blockers, anaesthesia, lithium)
  • Hypoglycaemia
  • Stroke
  • Surgery or trauma
  • Burns
  • Hypoxia
65
Q

Myxoedema coma presentation

A
  • Acute mental state changes (e.g. confusion) – common
  • Hypothermia (<35.5°C often)
  • Generalised swelling and puffiness due to oedema
  • Coarse hair
  • Dry skin
  • Bradycardia
  • Bradypnoea
  • Hypoxia
66
Q

investigations for myxoedemic coma

A

TFTs:
* TSH: usually raised
* T3 and T4: usually reduced

FBC:
* May show signs of infection (e.g. raised white cell count)

U&Es:
* May show hyponatraemia

Blood glucose:
* May be reduced

Serum cortisol:
- To rule out adrenal insufficiency which may co-exist with hypothyroidism in hypopituitarism

ABGs:
- May show hypoxia, hypercapnia, and respiratory acidosis

ECG:
* May show bradycardia

67
Q

management of myxoedemic coma

A
  • 1st-line: IV fluids + IV thyroid hormone replacement + IV hydrocortisone (until the possibility of coexisting adrenal insufficiency has been ruled out)
  • Correct hypoglycaemia and electrolyte disturbances
  • Consider non-invasive ventilation or intubation and ventilation
68
Q

sick euthyroid syndrome

A

low free T3 (FT3), free T4 (FT4), and low/normal thyroid-stimulating hormone (TSH).

It is generally seen in patients after critical illness, starvation, or intensive care. It is thought to occur due to changes in the hypothalamus-pituitary-thyroid axis.

Patients generally do not have symptoms and changes are reversible upon recovery. No treatment is generally needed.

69
Q

Hyperparathyroidism (HPT)

A

is characterised by an increased level of parathyroid hormone (PTH) in the blood. Increased levels of PTH cause serum calcium levels to increase and phosphate levels to fall.

70
Q

HPT types

A

Primary HPT:

  • The disorder is from within the parathyroid glands themselves

Secondary HPT:

  • The disorder is from somewhere else outside the parathyroid glands
  • This is usually in response to low calcium secondary to kidney, liver, or bowel disease

Tertiary HPT:

  • Usually seen in those with long-term secondary HPT. Eventually, this leads to parathyroid hyperplasia and autonomous PTH secretion
71
Q

Calcium and phosphate homeostasis

A
  1. PTH normally stimulates bone resorption, along with stimulating the kidneys to reabsorb calcium and convert 25-hydroxyvitamin D3 to its active form 1,25-hydroxyvitamin D3, which is responsible for the intestinal absorption of calcium.
  2. Low serum calcium stimulates PTH secretion, whereas high calcium levels suppress PTH secretion.
  3. PTH reduces the reabsorption of phosphate from the proximal tubules in the kidneys, leading to more phosphate excretion in the urine.
  4. Calcitonin is a hormone that opposes the effects of PTH and reduces serum calcium. It is released by thyroid parafollicular cells.
72
Q

Chronic kidney disease and secondary HPT

A

Patients with chronic kidney disease (CKD) excrete less phosphate due to dysfunction of the kidneys. This leads to the removal of calcium ions from the circulation as they are deposited in the insoluble salt calcium phosphate. This leads to hypocalcaemia and an increased level of potassium ions in the circulation, leading to secondary hyperparathyroidism.

73
Q

Primary hyperparathyroidism

A
  • Solitary parathyroid adenoma – 80% of cases
  • Parathyroid hyperplasia
  • Multiple parathyroid adenomas
  • Parathyroid malignancy
74
Q

Secondary hyperparathyroidism

A
  • Chronic kidney disease
  • Calcium loss/increased calcium demand
75
Q

Presentation: Primary hyperparathyroidism

A

The features of primary HPT and hypercalcaemia can be remembered using the mnemonic:

  • Bones – bone pain and fractures
  • Stones – renal stones
  • Abdominal groans – anorexia, nausea
  • Psychiatric moans – depression, insomnia, impaired memory
  • Thrones – constipation
  • An ECG may show QT interval shortening
76
Q

Presentation: Secondary hyperparathyroidism

A
  • Features of hypercalcaemia (mentioned above)
  • Features of chronic kidney disease
  • Features of malabsorption (e.g. coeliac disease, Crohn’s disease, chronic pancreatitis)
  • Features of osteomalacia (e.g. bone pain, fractures, or bowed legs in children)
  • Features of hypocalcaemia
77
Q

Investigations for hyperparathyroidism

A

Serum calcium:

  • Findings vary depending on the type of HPT

Serum phosphate:

  • Findings vary depending on the type of HPT

Parathyroid hormone:
- Findings vary depending on the type of HPT

Alkaline phosphatase (ALP):

  • Generally raised

X-ray:

  • May show **pepper pot skull **(salt and pepper sign) in the skull – these are multiple small well-defined areas of lucency in the skull cap
78
Q

investigation findings for primary HPT

A
  • elevated calcium
  • reduced phosphate
  • PTH: raised or inappropriately normal despite raised calcium
  • ALP: increased
79
Q

investigation findings for secondary HPT

A

when the glands are fine but a condition, like kidney failure, lowers calcium levels and causes the body to react by producing extra parathyroid hormone

  • reduced calcium
  • elevated phosphate
  • PTH: raised
  • ALP: increased
80
Q

investigation findings for tertiary HPT

A
  • normal/elevated calcium
  • reduced phosphate
  • PTH: raised
  • ALP: increased
81
Q

Primary hyperparathyroidism management

A
  • 1st-line: total parathyroidectomy
  • If unsuitable for/declines surgery: manage medically with calcimimetic (e.g. cinacalcet)
  • Cinacalcet binds to calcium-sensing receptors leading to the reduction of serum calcium and PTH – it mimics the effects of calcium
82
Q

management of secondary hyperparathyroidism

A

1st-line: manage underlying cause (e.g. offer vitamin D and calcium supplements for a patient with CKD)

83
Q

management of tertiary hyperparathyroidism

A

1st-line: watch and wait + consider partial/total parathyroidectomy

84
Q

complications of hyperparathyroidism

A

Complications

  • Osteoporosis
  • Bone fractures
  • Renal stones
  • Features of hypercalcaemia (e.g. depression, constipation, nausea)

Complications of surgery:

  • Hypocalcaemia
  • Recurrent laryngeal nerve palsy
  • Haematoma formation and airway obstruction
85
Q
A

Medicine (Year 5) (34 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions